Moreover, some patients exhibit varying therapeutic responses to the same CFTR modulator drugs, despite sharing the same CFTR mutation [[26], [27], [28]], suggesting that the underlying pathological mechanisms of CF are not fully understood. The gene discussed is CFTR; the disease is cystic fibrosis.